成人哮喘增加肥胖发生风险的长期国际队列研究
该研究基于欧洲社区呼吸健康调查(ECRHS)11国及澳大利亚的3波队列数据,纳入7576名(ECRHS I-II)和4976名(ECRHS II-III)基线非肥胖成人,采用多变量改良泊松回归分析。结果显示,哮喘患者发生肥胖的风险显著高于非哮喘者(RR 1.22,95%CI 1.07-1.38),且非特应性、病程>20年及口服糖皮质激素者风险更高。
要点
- 成人哮喘患者发生肥胖的风险较非哮喘者升高22%(RR 1.22,95%CI 1.07-1.38)。
- 非特应性哮喘(RR 1.47)及口服糖皮质激素者(RR 1.99)肥胖风险更高。
- 体力活动未介导哮喘与肥胖之间的关联。
核心结论
- 成人哮喘患者发生肥胖的风险显著高于非哮喘者,尤其见于非特应性、病程较长或使用口服糖皮质激素者。
研究设计与样本
- 欧洲社区呼吸健康调查(ECRHS)是一项在11个欧洲国家和澳大利亚开展、1990至2014年间共3波、间隔约10年的队列研究。
- 研究纳入ECRHS I-II期7576名(女性51.5%,平均年龄34岁,SD 7)和ECRHS II-III期4976名(女性51.3%,平均年龄42岁,SD 8)基线非肥胖(BMI<30 kg/m2)参与者。
- 采用多变量改良泊松回归(滞后)并重复测量,估计基线哮喘与随访时肥胖的相对风险(RR)。
主要发现
- ECRHS I-II期9%的参与者发生肥胖,ECRHS II-III期为15%。
- 哮喘患者发生肥胖的风险高于非哮喘者(RR 1.22,95%CI 1.07-1.38)。
- 非特应性哮喘者肥胖风险(RR 1.47,95%CI 1.17-1.86)高于特应性哮喘者(RR 1.04,95%CI 0.86-1.27)。
- 病程>20年者肥胖风险(RR 1.32,95%CI 1.10-1.59)高于病程≤20年者(RR 1.12,95%CI 0.87-1.43)。
- 使用口服糖皮质激素者肥胖风险(RR 1.99,95%CI 1.26-3.15)高于未使用者(RR 1.15,95%CI 1.03-1.28)。
临床怎么用
- 对成人哮喘患者,尤其非特应性、病程长或口服糖皮质激素者,应关注体重变化并早期干预肥胖。
- 哮喘管理中对高危患者可考虑将体重监测纳入长期随访内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Obesity is a known risk factor for asthma. Although some evidence showed asthma causing obesity in children, the link between asthma and obesity has not been investigated in adults. METHODS: We used data from the European Community Respiratory Health Survey (ECRHS), a cohort study in 11 European countries and Australia in 3 waves between 1990 and 2014, at intervals of approximately 10 years. We considered two study periods: from ECRHS I (t) to ECRHS II (t+1), and from ECRHS II (t) to ECRHS III (t+1). We excluded obese (body mass index≥30 kg/m2) individuals at visit t. The relative risk (RR) of obesity at t+1 associated with asthma at t was estimated by multivariable modified Poisson regression (lag) with repeated measurements. Additionally, we examined the association of atopy and asthma medication on the development of obesity. RESULTS: We included 7576 participants in the period ECRHS I-II (51.5% female, mean (SD) age of 34 (7) years) and 4976 in ECRHS II-III (51.3% female, 42 (8) years). 9% of participants became obese in ECRHS I-II and 15% in ECRHS II-III. The risk of developing obesity was higher among asthmatics than non-asthmatics (RR 1.22, 95% CI 1.07 to 1.38), and particularly higher among non-atopic than atopic (1.47; 1.17 to 1.86 vs 1.04; 0.86 to 1.27), those with longer disease duration (1.32; 1.10 to 1.59 in >20 years vs 1.12; 0.87 to 1.43 in ≤20 years) and those on oral corticosteroids (1.99; 1.26 to 3.15 vs 1.15; 1.03 to 1.28). Physical activity was not a mediator of this association. CONCLUSION: This is the first study showing that adult asthmatics have a higher risk of developing obesity than non-asthmatics, particularly those non-atopic, of longer disease duration or on oral corticosteroids.
引用
- Moitra S, Carsin AE, Abramson MJ, et al. Long-term effect of asthma on the development of obesity among adults: an international cohort study, ECRHS. Thorax. 2022. PMID: 35477559. doi:10.1136/thoraxjnl-2021-217867
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。